Blog16th July 2026CEO summer review 2026: advancing translational research through physiologically relevant iPSC‑derived models
Blog16th March 2026Patient stratification in Alzheimer’s disease: supporting preclinical in vitro model building and drug discovery with iPSCs
Blog3rd March 2026Microglia FAQ: applications, disease modeling, organoids, co‑cultures, screening & next‑gen advances
Blog23rd December 2025CEO end-of-year review 2025: building better human disease models for a changing world
Blog21st October 2017Guest Post: Are 3D neural cell cultures the best translational models towards finding a cure for Alzheimer’s disease?
Blog30th July 2024Interview between Duncan Borthwick Ph.D. and Jiro Kawada, Ph.D. Co-CEO Jiksak Bioengineering
Blog29th May 2024New product launch: new line, lower price axoCellsTM Astrocytes for better neurodegenerative disease modeling
Blog7th March 2024New product launch: axoCellsTM Atrial Cardiomyocyte kit for better arrhythmia and cardiotoxicity modeling
